Read the label on your medication bottle
The discovery is exciting because it suggests appetite suppression may be possible without the gastrointestinal and muscle-loss costs of current GLP-1 agonists, but the human translation has not yet happened
Activated mTORC1 combines with Syk and induces EZH2 expression to inhibit BACH2 transcription, resulting in increased expression of Blimp-1 and XBP1, which are essential for differentiation and antibody secretion of plasma B cells [73,74,75]
Some participants in GLP-1 weight loss programs have experienced more severe side effects, though they are less common
When demand for Wegovy and Ozempic surged in 2022 and Novo Nordisks manufacturing could not keep pace, the FDA placed semaglutide on its official drug shortage list
This may make it easier to follow a balanced diet without strict restrictions